Normal Reference Range for Neonatal Echocardiography (NORRNE)

July 13, 2024 updated by: Wang Jianhui, Children's Hospital of Chongqing Medical University

Normal Reference Range for Neonatal Echocardiography: a Multi-center, Prospective Study

Echocardiography is the main method of bedside examination of neonatal cardiac morphology, which can timely diagnose congenital heart disease and quantitatively assess its severity, but the diagnosis and evaluation process depends on the normal range of neonatal echocardiography.At present, there have been normal reference standards for echocardiography in children and adults at home and abroad, but there is no uniform standard for echocardiographic parameters in newborns, especially premature infants.This study intends to carry out a national multicenter, prospective, observational study to establish the reference range of echocardiography at different time periods after birth in newborns, and stratified according to gestational age, birth weight and gender, to conduct a more accurate hemodynamic assessment of clinically critically ill newborns and guide the treatment of critically ill newborns in real time.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Neonatal goal-directed echocardiography (TNE) performed by neonatologists has been increasingly applied to hemodynamic assessment in the NICU to guide critical neonatal treatment in real time. There are many detection indexes of TNE, which are closely related to neonatal weight, birth weight, postnatal age, race and other factors. Therefore, establishing neonatal echocardiographic reference ranges is essential for the development of TNE. At present, there have been normal reference standards for echocardiography in children and adults at home and abroad, but there is no uniform standard for echocardiographic parameters in newborns, especially premature infants. At present, there are many problems in establishing the reference range of neonatal echocardiography internationally, including the small sample size included in establishing the reference range, no premature infant standard for some parameters, the reference range is not stratified according to gender, etc. Moreover, the majority of current echocardiographic reference ranges are derived from studies in European and American populations and are not applicable to Asian patients. So far, reference ranges for neonatal echocardiography established based on high-quality clinical studies are still lacking, greatly affecting the use of echocardiography in neonatal intensive care units. Therefore, this study intends to carry out a national multicenter, prospective, observational study to establish the reference range of echocardiography at different time periods after birth in neonates, and stratify according to creatinine, birth weight and gender, providing a reference for the application of echocardiography in neonatal intensive care units, and providing an important basis for the development of TNE-centered neonatal hemodynamic comprehensive assessment program in the NICU.

  1. Study Design and Process:

    This study is a multicenter, prospective, observational study. Neonatal bedside echocardiography was performed by a trained neonatology clinician or sonographer. Five time points were selected for neonatal echocardiography, namely, 1 day, 3 days, 7 days, 14 days, and 28 days after birth. The examination was completed in the quiet state of the newborn, and the measurement method was based on the American Guidelines and Standards for Echocardiography in Children and the American NICU Echocardiography Practice Guidelines. All ultrasound data were averaged over three or more cardiac cycles.

  2. Sample Size Calculation:

    Each participating NICU will be required to enroll 300 infants (60 infants for each PNA timepoint) for a final sample size of 1500 "normal infants".

  3. Statistical Methods:

    Data statistics were performed using SPSS 21.0 software. The data obtained for each of the ultrasound hemodynamic parameters were tested for normality. The measurement data conforming to normal distribution are expressed by mean ± standard deviation, and the measurement data with non-normal distribution are expressed by median (interquartile range). Spearman correlation analysis was used to compare the correlation between different indicators and postnatal, birth weight, birth weight and gender. The echocardiographic reference range of newborns at different time periods after birth was established by 95% confidence interval and stratified according to birth weight, birth weight and gender. P < 0.05 was considered statistically significant.

  4. Quality control:

At the beginning of the study, a cooperative group kick-off meeting will be organized to interpret the study protocol in detail. In addition, the online or offline training of the participating units will be carried out to further unify the parameter setting and data collection criteria of the ultrasound machine. Establish a WeChat group to answer questions related to this study at any time. During the process of the project, regular contact meetings within the cooperative group will be held to ensure that the investigators participating in the study will implement the protocol. During the study, the study site will assign a special person to review the completeness and correctness of the data submitted by each participating site.

Study Type

Observational

Enrollment (Estimated)

1500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Dong Wenhui, Master
  • Phone Number: +8615826122681
  • Email: 376561086@qq.com

Study Locations

    • Chongqing
      • Chongqing, Chongqing, China, 400014
        • Recruiting
        • Children's Hospital of Chongqing Medical University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 day to 4 weeks (Child)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

healthy neonates and preterm Infants

Description

Inclusion Criteria:

  • Outpatient or inpatient neonate
  • Gestational age > 30weeks and birthweight > 1250 grams
  • Appropriate for gestational age
  • Without perinatal asphyxia
  • Without skin lesion on the left chest wall
  • with family informed consent for neonatal echocardiography

Exclusion Criteria:

  • specialist cardiac ultrasound suggests congenital heart disease;
  • PDA with hemodynamic abnormalities, defined as: PDA > 1.5 mm (left-to-right shunt) and left atrial diameter/aortic root > 1.5 or the need for the use of inotropes;
  • invasive mechanical ventilation therapy,
  • non-invasive mechanical ventilation with FiO2 >0.3
  • major anomalies
  • blood culture-proven neonatal sepsis
  • persistent pulmonary hypertension
  • renal failure
  • necrotizing enterocolitis ≥ stage II
  • post surgery
  • Maternal history of severe anemia, or prenatal massive bleeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in left atrial anteroposterior diameter with increasing age
Time Frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
The Left atrial systolic anteroposterior diameter was measured by M-mode ultrasound through the aortic root in the long axis of the parasternal left ventricle
5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
Changes in interventricular septum thickness with increasing age
Time Frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
The Interventricular septal thickness was measured by left ventricular M-mode ultrasound in the long axis of the parasternal left ventricle
5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
Changes in left ventricular posterior wall thickness at end diastole with increasing age
Time Frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
The left ventricular posterior wall thickness at end diastole was measured by left ventricular M-mode ultrasound in the long axis of the parasternal left ventricle
5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
Changes in left ventricular end diastolic diameter with increasing age
Time Frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
The left ventricular end diastolic diameter was measured by left ventricular M-mode ultrasound in the long axis of the parasternal left ventricle
5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
Changes in left ventricular end systolic diameter with increasing age
Time Frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
The left ventricular end systolic diameter was measured by left ventricular M-mode ultrasound in the long axis of the parasternal left ventricle
5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
Changes in right ventricular anteroposterior diameter at end diastole with increasing age
Time Frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
The right ventricular anteroposterior diameter at end diastole was measured by left ventricular M-mode ultrasound in the long axis of the parasternal left ventricle
5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
Changes in right ventricular outflow tract diameter with increasing age
Time Frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
The right ventricular outflow tract diameter was measured in the short-axis pulmonary valve orifice view of the parasternal great arteries
5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
Changes in left ventricular ejection fraction with increasing age
Time Frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
Left ventricular ejection fraction can be calculated by measuring left ventricular end-diastolic diameter and left ventricular end-systolic diameter in a standard parasternal left ventricular long-axis view, at the level of mitral chordae tendineae, or parasternal left ventricular short-axis view, at the level of papillary muscles, with the sampling line perpendicular to the interventricular septum and left ventricular posterior wall
5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in left ventricular outflow tract diameter with increasing age
Time Frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
In the standard parasternal long-axis view, images were frozen when the aortic valve was completely opened during systole, and the distance between the anterior and posterior aortic walls at the level of aortic root attachment was measured with an electronic cursor to obtain the left ventricular outflow tract diameter
5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
Changes in main pulmonary artery diameter with increasing age
Time Frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
In the parasternal cardiac base short-axis view, the left and right pulmonary arteries were exposed at the same time, and the diameter of the main pulmonary artery was measured
5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
Changes in Inferior vena cava diameter with increasing age
Time Frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
Inferior vena cava diameter was measured by M-mode ultrasound in the subxiphoid long-axis plane by transthoracic ultrasound
5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
Changes in Simpson 's method for measuring ejection fraction with increasing age
Time Frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
Through the apical four-chamber view or apical two-chamber view, for the tracing of diastolic and systolic endocardium, divide the heart into several (generally 20) cylinders, calculate the volume and add them to obtain the left ventricular end-diastolic and end-systolic volumes, and then calculate the ejection fraction
5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Aortic Velocity Time Integral(VTI)with increasing age
Time Frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)
In the apical five-chamber view, select the color Doppler mode to display the aortic blood flow signal and direction, place the sampling volume below the arterial orifice, adjust the blood flow direction as parallel as possible to the sampling line through the left and right swing probe, and select the pulsed Doppler mode (PW), then the velocity time integral (VTI) image of aortic blood flow can be obtained. Trace the aortic velocity-time integral image and calculate the VTI value in cm by computer or plotter. Select 3-5 consecutive VTI images within the same respiratory cycle for measurement and average to reduce the impact of the respiratory cycle
5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2022

Primary Completion (Estimated)

December 30, 2024

Study Completion (Estimated)

December 30, 2024

Study Registration Dates

First Submitted

June 25, 2022

First Submitted That Met QC Criteria

July 14, 2022

First Posted (Actual)

July 18, 2022

Study Record Updates

Last Update Posted (Actual)

July 16, 2024

Last Update Submitted That Met QC Criteria

July 13, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-06-10

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe